Effects of Pluronic F68 and Labrasol on the intestinal absorption and pharmacokinetics of rifampicin in rats

Archives of Pharmacal Research

Volumn 34, Issue 11, 2011, Pages 1939-1943

  Ma, Li ^a   Wei, Yuhui ^a   Zhou, Yan ^a   Ma, Xiaohua ^a   Wu, Xin'An ^a  

^a LANZHOU UNIVERSITY   (China)

Author keywords

Intestinal absorption; Labrasol; P gp; Pharmacokinetics; Pluronic F68; Rifampicin

Indexed keywords

EXCIPIENT; LABRASOL; POLOXAMER; RIFAMPICIN; VERAPAMIL;

ARTICLE; CONTROLLED STUDY; DRUG CLEARANCE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IN SITU SINGLE PASS PERFUSION; INTESTINE ABSORPTION; INTESTINE MUCOSA PERMEABILITY; MALE; NONHUMAN; PERFUSION; RAT;

ANIMALS; ANTIBIOTICS, ANTITUBERCULAR; DRUG COMPOUNDING; EMULSIFYING AGENTS; EXCIPIENTS; HALF-LIFE; INTESTINAL ABSORPTION; MALE; MEMBRANE TRANSPORT MODULATORS; METABOLIC CLEARANCE RATE; ORGANIC CHEMICALS; P-GLYCOPROTEIN; PERFUSION; PERMEABILITY; POLOXAMER; RANDOM ALLOCATION; RATS; RATS, WISTAR; RIFAMPIN; SURFACE-ACTIVE AGENTS;

EID: 83655203481     PISSN: 02536269     EISSN: 19763786     Source Type: Journal    
DOI: 10.1007/s12272-011-1114-z     Document Type: Article

References (19)

1. T. Bansal G. Mishra M. Jaggi R. K. Khar S. Talegaonkar 2009 Effect of P-glycoprotein inhibitor, verapamil, on oral bioavailability and pharmacokinetics of irinotecan in rats Eur. J. Pharm. Sci. 36 580 590 19135530 10.1016/j.ejps.2008.12.005 1:CAS:528:DC%2BD1MXhs1aqurk%3D
2. W. J. Burman K. Gallicano C. Peloquin 2001 Comparative pharmacokinetics and pharmacodynamics of the rifamycin antibacterials Clin. Pharmacokinet. 40 327 341 11432536 10.2165/00003088-200140050-00002 1:CAS:528:DC%2BD3MXltV2ks7k%3D (Pubitemid 32565595)
3. Z. Hu R. Tawa T. Konishi N. Shibata K. Takada 2001 A novel emulsifier, labrasol, enhances gastrointestinal absorption of gentamicin Life Sci. 69 2899 2910 11720093 10.1016/S0024-3205(01)01375-3 1:CAS:528:DC%2BD3MXotl2gtrY%3D (Pubitemid 33030278)
4. J. Huang L. Si L. Jiang Z. Fan J. Qiu G. Li 2008 Effect of pluronic F68 block copolymer on P-glycoprotein transport and CYP3A4 metabolism Int. J. Pharm. 356 351 353 18242899 10.1016/j.ijpharm.2007.12.028 1:CAS:528: DC%2BD1cXlsFCks7Y%3D
5. C. Issa P. Gupta A. K. Bansal 2003 Implications of density correction in gravimetric method for water flux determination using rat single-pass intestinal perfusion technique: a technical note AAPS PharmSciTech 4 E16 12916898 10.1208/pt040216
6. R. Jain S. Duvvuri V. Kansara N. K. Mandava A. K. Mitra 2007 Intestinal absorption of novel-dipeptide prodrugs of saquinavir in rats Int. J. Pharm. 336 233 240 17207946 10.1016/j.ijpharm.2006.11.058 1:CAS:528:DC%2BD2sXkvFWqur4%3D (Pubitemid 46670646)
7. J. R. Koup J. Williams-Warren C. T. Viswanathan A. Weber A. L. Smith 1986 Pharmacokinetics of rifampin in children. II. Oral bioavailability Ther. Drug Monit. 8 17 22 3961891 10.1097/00007691-198603000-00004 1:STN:280: DyaL287otVylsQ%3D%3D (Pubitemid 16166117)
8. Y. Lin Q. Shen H. Katsumi N. Okada T. Fujita X. Jiang A. Yamamoto 2007 Effects of Labrasol and other pharmaceutical excipients on the intestinal transport and absorption of rhodamine123, a P-glycoprotein substrate, in rats Biol. Pharm. Bull. 30 1301 1307 17603171 10.1248/bpb.30.1301 1:CAS:528:DC%2BD2sXps1alu7g%3D (Pubitemid 47037658)
9. T. T. Mariappan S. Singh 2004 Evidence of efflux-mediated and saturable absorption of rifampicin in rat intestine using the ligated loop and everted gut sac techniques Mol. Pharm. 1 363 367 16026006 10.1021/mp049937n 1:CAS:528:DC%2BD2cXmslaqt7c%3D
10. D. A. Mitchison 1992 The Garrod Lecture. Understanding the chemotherapy of tuberculosis-current problems J. Antimicrob. Chemother. 29 477 493 1624388 10.1093/jac/29.5.477 1:STN:280:DyaK38zisV2ltw%3D%3D
11. M. M. Nerurkar N. F. Ho P. S. Burton T. J. Vidmar R. T. Borchardt 1997 Mechanistic roles of neutral surfactants on concurrent polarized and passive membrane transport of a model peptide in Caco-2 cells J. Pharm. Sci. 86 813 821 9232522 10.1021/js960483y 1:CAS:528:DyaK2sXjslCktrk%3D (Pubitemid 27297493)
12. R. Pandey A. Sharma A. Zahoor S. Sharma G. K. Khuller B. Prasad 2003 Poly (DL-lactide-co-glycolide) nanoparticle-based inhalable sustained drug delivery system for experimental tuberculosis J. Antimicrob. Chemother. 52 981 986 14613962 10.1093/jac/dkg477 1:CAS:528:DC%2BD3sXpvVels7g%3D (Pubitemid 38008419)
13. A. Pargal S. Rani 2001 Non-linear pharmacokinetics of rifampicin in healthy Asian Indian volunteers Int. J. Tuberc. Lung Dis. 5 70 79 11263520 1:STN:280:DC%2BD3M7mtlehtw%3D%3D (Pubitemid 32401879)
14. G. Pillai P. B. Fourie N. Padayatchi P. C. Onyebujoh H. McIlleron P. J. Smith G. Gabriels 1999 Recent bioequivalence studies on fixed-dose combination antituberculosis drug formulations available on the global market Int. J. Tuberc. Lung Dis. 3 S309 S316 10593710 1:STN:280:DC%2BD3c%2FlvFaruw%3D%3D
15. B. D. Rege J. P. Kao J. E. Polli 2002 Effects of nonionic surfactants on membrane transporters in Caco-2 cell monolayers Eur. J. Pharm. Sci. 16 237 246 12208453 10.1016/S0928-0987(02)00055-6 1:CAS:528:DC%2BD38Xms1ynsro%3D
16. J. D. Schulze E. E. Peters A. W. Vickers J. S. Staton M. D. Coffin G. E. Parsons A. W. Basit 2005 Excipient effects on gastrointestinal transit and drug absorption in beagle dogs Int. J. Pharm. 300 67 75 15979264 10.1016/j.ijpharm. 2005.05.004 1:CAS:528:DC%2BD2MXmvFCqsbc%3D (Pubitemid 41112168)
17. C. J. Shishoo S. A. Shah I. S. Rathod S. S. Savale M. J. Vora 2001 Impaired bioavailability of rifampicin in presence of isoniazid from fixed dose combination (FDC) formulation Int. J. Pharm. 228 53 67 11576768 10.1016/S0378-5173(01)00831-6 1:CAS:528:DC%2BD3MXntVWrsr4%3D (Pubitemid 32905365)
18. 14C-PEG-3350 methods to determine water absorption in the rat singlepass intestinal perfusion model AAPS PharmSci. 3 E25 11741276 10.1208/ps030325 1:CAS:528:DC%2BD3MXnsFyqsL8%3D
19. M. V. Varma R. Panchagnula 2005 Enhanced oral paclitaxel absorption with vitamin E-TPGS: effect on solubility and permeability in vitro, in situ and in vivo Eur. J. Pharm. Sci. 25 445 453 15890503 10.1016/j.ejps.2005.04.003 1:CAS:528:DC%2BD2MXlsVCltbg%3D (Pubitemid 40853872)